Fulcrum Therapeutics, Inc. (NASDAQ:FULC)

About the company

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF. The company was founded by Michael R. Green, Danny Reinberg, Rudolf Jaenisch, Jeannie T. Lee, and Bradley E. Bernstein on August 18, 2015 and is headquartered in Cambridge, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

73

CEO

Robert J. Gould

Exchange

NASDAQ

Website

http://www.fulcrumtx.com

$3.00M

Total Revenue

73

Employees

$230.31M

Market Capitalization

-3.44

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$M

Operating Margin (in %)

Total operating margin

$M

Net Margin (in %)

Total net margin

$M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 398459.76 80503.00 6.24 26.22 18.86
Merck & Co., Inc. MRK 219072.92 47194.00 7.85 20.88 22.20
Pfizer Inc. PFE 206153.65 49197.00 3.16 14.48 28.80
Eli Lilly & Co. LLY 140911.38 22949.00 36.02 24.87 24.48
AbbVie, Inc. ABBV 137597.97 36227.00 10.82 19.72 19.06
Bristol Myers Squibb Co. BMY 119962.48 34862.00 2.72 -204.38 -1.61
Royalty Pharma Plc RPRX 25481.86 1922.00 6.13 36.19 36.50
Repligen Corp. RGEN 7591.48 302.00 6.97 256.12 10.23
Allakos, Inc. ALLK 4037.76 None 9.20 -35.64 None
Nektar Therapeutics NKTR 3570.09 163.00 2.87 -8.30 -264.25
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3493.05 11.00 -107.64 -5.80 None
Reata Pharmaceuticals, Inc. RETA 3375.68 15.00 15.31 -9.65 -150.30
ADC Therapeutics SA ADCT 3230.50 2.00 16.37 -13.58 None
Turning Point Therapeutics, Inc. TPTX 3188.52 None 5.25 -27.09 None
Principia Biopharma, Inc. PRNB 3008.10 50.00 9.49 -40.60 -137.82
IGM Biosciences, Inc. IGMS 2600.28 None 12.43 -41.73 None
Apellis Pharmaceuticals, Inc. APLS 2250.09 None 10.62 -4.84 None
Zymeworks, Inc. ZYME 2130.98 30.00 4.21 -11.57 -569.13
Karuna Therapeutics, Inc. KRTX 2117.50 None 6.06 0.17 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 2102.27 None 7.23 -30.75 None
Forma Therapeutics Holdings, Inc. FMTX 1992.76 11.00 4.51 -35.38 -513.80
OPKO Health, Inc. OPK 1974.91 966.00 1.34 -9.61 -20.69
Akcea Therapeutics, Inc. AKCA 1815.00 337.00 3.85 -49.05 -12.34
Y-mAbs Therapeutics, Inc. YMAB 1635.14 None 11.79 -14.44 None
Y-mAbs Therapeutics, Inc. YMAB 1587.64 None 11.45 -14.02 None
Generation Bio Co. GBIO 1336.95 0.00 4.54 -19.81 None
Repare Therapeutics, Inc. RPTX 1220.63 None 3.87 -31.12 None
Athenex, Inc. ATNX 1050.40 141.00 8.64 -9.12 -82.63
Akero Therapeutics, Inc. AKRO 1036.00 None 12.37 10.85 None
Arcutis Biotherapeutics, Inc. ARQT 1000.92 None 4.82 -10.98 None
Phathom Pharmaceuticals, Inc. PHAT 986.44 None 5.15 -4.68 None
Kiniksa Pharmaceuticals Ltd. KNSA 965.44 None 4.67 -7.91 None
Quanterix Corp. QTRX 949.20 60.00 9.60 -21.19 -74.92
Keros Therapeutics, Inc. KROS 903.80 5.00 6.45 -31.38 -581.22
Krystal Biotech, Inc. KRYS 872.82 None 3.08 -39.42 None
Gossamer Bio, Inc. GOSS 825.93 None 2.24 -3.66 None
Constellation Pharmaceuticals, Inc. CNST 793.44 None 2.22 -7.90 None
Phibro Animal Health Corp. PAHC 736.36 800.00 3.86 21.64 4.19
Arcturus Therapeutics Holdings, Inc. ARCT 703.35 11.00 12.24 -17.97 -341.76
Annexon, Inc. ANNX 697.50 None -7.28 -18.44 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 636.16 1739.00 4.39 -2.91 -11.16
Aprea Therapeutics, Inc. APRE 620.76 None 6.25 -13.88 None
Oric Pharmaceuticals, Inc. ORIC 617.70 None 3.22 -17.75 None
SIGA Technologies, Inc. SIGA 611.72 55.00 6.17 124.33 11.35
Ocular Therapeutix, Inc. OCUL 582.12 7.00 115.50 -4.64 None
G1 Therapeutics, Inc. GTHX 578.74 2.00 2.84 -4.40 None
Tricida, Inc. TCDA 568.00 None 2.46 -2.40 None
Nurix Therapeutics, Inc. NRIX 555.20 19.00 12.05 -26.69 -106.51
Oyster Point Pharma, Inc. OYST 545.74 None 2.45 -8.53 None
Fusion Pharmaceuticals, Inc. FUSN 520.80 None 1.64 -7.95 None
Mirum Pharmaceuticals, Inc. MIRM 493.50 None 3.68 -6.37 None
TCR2 Therapeutics, Inc. TCRR 486.72 None 5.07 -9.99 None
Inozyme Pharma, Inc. INZY 479.40 None -11.20 -17.50 None
Odonate Therapeutics, Inc. ODT 466.24 None 5.49 -3.95 None
Applied Therapeutics, Inc. APLT 462.84 14.00 4.20 -6.64 -19.41
Imara, Inc. IMRA 429.25 None 4.11 -11.17 None
Crinetics Pharmaceuticals, Inc. CRNX 410.02 1.00 2.56 -6.54 -447.78
Kala Pharmaceuticals, Inc. KALA 403.03 5.00 4.27 -4.37 None
Biospecifics Technologies Corp. BSTC 397.53 35.00 3.22 22.90 52.45
DURECT Corp. DRRX 368.15 50.00 10.28 -185.00 -3.66
Relmada Therapeutics, Inc. RLMD 361.62 0.00 4.87 -30.21 -877.66
89bio, Inc. ETNB 357.42 None 6.17 -5.84 None
AMAG Pharmaceuticals, Inc. AMAG 343.74 298.00 1.40 -1.33 -86.95
Ovid Therapeutics, Inc. OVID 334.50 None 13.94 -4.37 None
TFF Pharmaceuticals, Inc. TFFP 313.69 None 16.51 -7.82 None
Urovant Sciences Ltd. UROV 313.41 None -3.72 -2.08 None
Sutro Biopharma, Inc. STRO 308.36 40.00 2.06 -13.95 -43.34
Osmotica Pharmaceuticals Plc OSMT 299.75 212.00 2.66 -1.85 -73.47
HOOKIPA Pharma, Inc. HOOK 286.26 16.00 2.72 -10.90 -247.22
Aquestive Therapeutics, Inc. AQST 271.50 59.00 -14.14 -5.14 -84.20
IDEAYA Biosciences, Inc. IDYA 263.40 None 2.22 -59.86 None
Lannett Co., Inc. LCI 248.82 546.00 0.85 -7.42 -6.11
KalVista Pharmaceuticals, Inc. KALV 248.22 9.00 2.95 -7.54 -349.66
Verrica Pharmaceuticals, Inc. VRCA 239.75 None 5.10 -7.27 None
Cyclerion Therapeutics, Inc. CYCN 234.92 5.00 4.30 -2.48 None
Fulcrum Therapeutics, Inc. FULC 230.31 3.00 1.92 -3.44 None
Milestone Pharmaceuticals, Inc. MIST 222.00 None 2.49 -7.28 None
Galera Therapeutics, Inc. GRTX 205.25 None 5.07 -2.90 None
Immunic, Inc. IMUX 202.18 None 4.84 -7.02 None
Xeris Pharmaceuticals, Inc. XERS 196.54 6.00 11.96 -1.60 None
Spero Therapeutics, Inc. SPRO 192.09 12.00 2.91 -2.31 -713.29
Veru, Inc. VERU 190.08 40.00 4.88 -18.00 -25.78
Avenue Therapeutics, Inc. ATXI 184.00 532.00 46.00 -18.25 26.69
Kaleido Biosciences, Inc. KLDO 182.90 0.00 4.10 -2.36 None
Ayala Pharmaceuticals, Inc. AYLA 175.50 3.00 3.20 -7.18 -728.78
Eton Pharmaceuticals, Inc. ETON 172.14 1.00 26.65 -8.09 None
Mustang Bio, Inc. MBIO 162.96 None 3.08 -3.03 None
Harrow Health, Inc. HROW 161.98 45.00 10.21 -7.24 -48.54
NeuBase Therapeutics, Inc. NBSE 156.24 None 5.79 -2.90 None
Evelo Biosciences, Inc. EVLO 155.20 None 3.23 -1.78 None
Lyra Therapeutics, Inc. LYRA 155.09 1.00 1.78 -8.77 -491.16
LogicBio Therapeutics, Inc. LOGC 153.64 2.00 5.61 -3.82 None
Checkpoint Therapeutics, Inc. CKPT 153.00 1.00 13.60 -6.54 -873.97
scPharmaceuticals, Inc. SCPH 149.20 119.00 2.08 -4.60 -27.05
Liquidia Technologies, Inc. LQDA 139.44 8.00 25.26 -2.35 -589.48
Corvus Pharmaceuticals, Inc. CRVS 129.05 None 2.46 -2.87 None
Evolus, Inc. EOLS 119.97 51.00 3.00 -1.47 -161.74
Tyme Technologies, Inc. TYME 119.18 None 8.42 -4.39 None
Gritstone Oncology, Inc. GRTS 118.80 4.00 1.29 -1.11 None
Protara Therapeutics, Inc. TARA 109.98 None 1.81 -3.67 None
PhaseBio Pharmaceuticals, Inc. PHAS 105.85 1.00 4.06 -1.59 None
Lantern Pharma, Inc. LTRN 98.82 None 4.40 -38.30 None
Genprex, Inc. GNPX 91.20 None 6.03 -6.44 None
Satsuma Pharmaceuticals, Inc. STSA 78.71 None 0.86 -1.92 None
Menlo Therapeutics, Inc. MNLO 76.95 13.00 3.14 -0.35 -483.51
Clearside Biomedical, Inc. CLSD 74.39 7.00 10.81 -4.22 -280.03
Trevi Therapeutics, Inc. TRVI 72.36 None 1.84 -4.73 None
Edesa Biotech, Inc. EDSA 69.66 0.00 13.58 -0.73 -395.23
EyePoint Pharmaceuticals, Inc. EYPT 67.26 23.00 19.67 -1.28 -229.33
Aridis Pharmaceuticals, Inc. ARDS 66.06 1.00 -10.79 -2.74 -851.00
BiomX, Inc. PHGE 66.00 None 1.89 -1.54 None
Baudax Bio, Inc. BXRX 62.10 0.00 -1.07 -0.72 None
Aerpio Pharmaceuticals, Inc. ARPO 61.50 15.00 1.49 -16.67 -24.91
Eyenovia, Inc. EYEN 61.02 None 9.97 -3.11 None
Assertio Holdings, Inc. ASRT 58.80 156.00 0.89 -0.27 -117.10
Navidea Biopharmaceuticals, Inc. NAVB 58.80 1.00 -32.67 -5.65 -65.13
Adamis Pharmaceuticals Corp. ADMP 46.80 20.00 2.32 -1.41 -170.82
ProPhase Labs, Inc. PRPH 46.44 11.00 4.12 -27.64 -14.31
Moleculin Biotech, Inc. MBRX 44.50 None 3.56 -2.34 None
Aileron Therapeutics, Inc. ALRN 39.44 None 3.24 -1.51 None
Annovis Bio, Inc. ANVS 37.31 None 3.86 -11.34 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
AgeX Therapeutics, Inc. AGE 34.81 2.00 -15.27 -2.86 -625.09
Oncternal Therapeutics, Inc. ONCT 34.72 2.00 4.93 2.55 -778.44
Allena Pharmaceuticals, Inc. ALNA 34.25 None 2.85 -0.86 None
Mannatech, Inc. MTEX 34.00 153.00 1.45 9.04 2.96
Citius Pharmaceuticals, Inc. CTXR 33.28 None 2.00 -1.93 None
CNS Pharmaceuticals, Inc. CNSP 28.20 None 8.17 -3.76 None
Millendo Therapeutics, Inc. MLND 25.92 0.00 0.70 -0.55 None
Acer Therapeutics, Inc. ACER 25.90 3.00 2.76 -1.25 -274.69
Hoth Therapeutics, Inc. HOTH 25.85 None 4.61 -2.42 None
PDS Biotechnology Corp. PDSB 25.47 None 3.72 -1.07 None
Spring Bank Pharmaceuticals, Inc. SBPH 23.80 0.00 1.04 -0.80 None
Novan, Inc. NOVN 22.96 5.00 -0.52 -0.64 -572.98
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 21.84 1.00 104.00 -1.22 None
Sun BioPharma, Inc. SNBP 21.56 1.00 18.12 -4.67 -7.89
Adial Pharmaceuticals, Inc. ADIL 14.52 None 2.03 -1.81 None
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novus Therapeutics, Inc. NVUS 13.36 None 1.86 -0.78 None
Titan Pharmaceuticals, Inc. TTNP 12.81 5.00 10.50 -1.91 -351.69
Brickell Biotech, Inc. BBI 5.81 10.00 1.15 -0.26 -165.28
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Fulcrum Therapeutics to Participate in Upcoming Investor Conferences

12d ago, source: Business Insider

Sept. 08, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare ...

Fulcrum Therapeutics Inc

1mon ago, source: Reuters

Aug 11 (Reuters) - Fulcrum Therapeutics Inc <FULC.O>::FULCRUM THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND SECOND QUARTER 2020 FINANCIAL RESULTS.FULCRUM THERAPEUTICS INC - ON TRACK TO SHARE ...

Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results

1mon ago, source: Nasdaq

CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with ...

Fulcrum Therapeutics'(NASDAQ:FULC) Share Price Is Down 33% Over The Past Year.

1mon ago, source: YAHOO!

For example, the Fulcrum Therapeutics, Inc. (NASDAQ:FULC) share price is down 33% in the last year. That's well below the market return of 19%. Fulcrum Therapeutics may have better days ahead ...

Fulcrum Therapeutics Inc Registered Shs Buy

1mon ago, source: Business Insider

Disclaimer | Commerce Policy | Made In NYC | Stock quotes by finanzen.net Summary: Fulcrum Therapeutics Inc Registered Shs Buy Analyst Opinions for Fulcrum Therapeutics Inc Registered ShsMore ...

Fulcrum Therapeutics Announces Interim Analysis Data from its ReDUX4 Trial in Facioscapulohumeral Muscular Dystrophy (FSHD)

1mon ago, source: Stockhouse

Aug. 11, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare ...

Power to the Patient: Meet Xconomy’s Patient Partnership Award Finalists

23d ago, source: Xconomy

The founders of Fulcrum reached out to patient groups to figure out which diseases to go after, even before the company was officially formed in 2016. Those early conversations led the company to ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.